High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells

South Africa News News

High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells
South Africa Latest News,South Africa Headlines
  • 📰 ScienceMagazine
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

Mice can make neutralizing antibodies to SARSCoV2 via a complementary pathway not requiring follicular helper T cells or GerminalCenters, says new research from SciImmunology.

mice were infected with 70 PFU of PR8. All work with SARS-CoV-2 was performed in a biosafety level 3 facility with approval from the office of Environmental Health and Safety and the Institutional Animal Care and Use Committee at Yale University.Used vials of Moderna mRNA-1273 and Pfizer-BioNTech BNT162b2 mRNA vaccine were obtained from Yale Health within 6 hours of opening. All vials contained less than one full dose per vial, and no vaccines were diverted for the purpose of this study.

For cell sorting, medLN were stained with aforementioned B cell surface markers and viability dye, along with 2 μg/ml FLAG-tagged SARS-CoV-2 spike protein for 30 min at 4°C . Cells were then stained with both APC- and PE-conjugated anti-FLAG antibodies to double-stain spike-specific B cells. Spike-specific plasmablasts were sorted into 350 μl Buffer RLT Plus with 1% β-mercaptoethanol. RLT lysate was vortexed for 1 min, frozen on dry ice, and then stored at -80°C.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ScienceMagazine /  🏆 285. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronA Nature research paper reports reduced effectiveness of vaccine- or infection-elicited antibodies against the SARS-CoV-2 Omicon variant, relative to other viral lineages
Read more »

Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronA Nature research paper reports reduced effectiveness of vaccine- or infection-elicited antibodies against the SARS-CoV-2 Omicon variant, relative to other viral lineages
Read more »

Virus leaves antibodies that may attack healthy tissues; B cell antibodies weakened, not defeated by OmicronVirus leaves antibodies that may attack healthy tissues; B cell antibodies weakened, not defeated by OmicronThe following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
Read more »

Made up of Hong Kong domestic helpers, this cricket team is making waves -- and changing perceptionsMade up of Hong Kong domestic helpers, this cricket team is making waves -- and changing perceptions'When I started to try out this game I didn't expect that much' the team captain told CNNSport. Little did she know, within the next five years, the Divas would reach Division 1 in Hong Kong and become the backbone of the Philippine national cricket team
Read more »

San Francisco launches new recycling program making it easier to get cash for cansSan Francisco launches new recycling program making it easier to get cash for cansSan Francisco is launching a new mobile recycling program.
Read more »

Polyclonal antibody treatment for COVID-19 moves to phase 3 trial at UT SouthwesternPolyclonal antibody treatment for COVID-19 moves to phase 3 trial at UT SouthwesternResearchers at the University of Texas Southwestern Medical Center are studying a polyclonal antibody therapy to treat non-hospitalized people with early...
Read more »



Render Time: 2025-03-09 04:57:48